Fort Belvoir, Virginia, Oct. 24, 2017 -- Collaboration between government, academia and industry is key to defending our warfighters and nation from the evolving threat of weapons of mass destruction. Share innovative ideas with more than 1,500 of the most influential scientists, program managers and leaders in the defense community at the 2017 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Nov. 28-30, 2017, in Long Beach, Calif.
|
|||||||||
The event will feature the latest developments in basic and applied scientific research within the chemical and biological defense arena including:
- Novel Threat and Disruptive Chemical and Biological Discovery
- Dynamic Functional Materials
- Applied Mathematics and Innovative Computational Tools
- Flexible Design, Synthesis and Manufacturing
- Systems Biology and Engineering
- Disease Surveillance, Characterization and Point of Need Diagnostics
- Adaptive Medical Therapeutics and Technologies
- Rapid Response and Recovery Science and Technology
- Threat Activity Sensing and Reporting
Theoretical physicist, S. James Gates, Jr., Ph.D., specializing in supersymmetry, supergravity and superstring theory, and Ford Foundation Professor of Physics at Brown University, will deliver the keynote address. In addition, special sessions will offer a CBD S&T portfolio overview and a ‘how-to’ conduct business with DTRA presentation, a warfighter panel and a minority-serving institution panel.
Registration is now open. Visit www.cbdstconference.com for registration information.
###
The DTRA mission is to safeguard the U.S. and its allies from weapons of mass destruction (WMD), specifically chemical, biological, radiological, nuclear, and high-yield explosive threats, and improvised threats by providing the means to prevent and counter the proliferation of WMD and improvised threats and to reduce, eliminate, and mitigate their effects. This includes helping ensure the U.S. maintains a safe, secure, effective and credible nuclear weapons deterrent. As the DoD Combat Support Agency for the Counter WMD and improvised threats mission, DTRA develops and provides operational support for associated capabilities to warfighters worldwide.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5ac4dd5a-7778-49f2-9c31-f4d47a30a65d
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3d004a69-a8cc-4447-8523-f5de3f28d6d5
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/59f0c34e-0c34-463a-86f7-3a71e677d1d8
Defense Threat Reduction Agency 703-767-6050 [email protected]


Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 



